By Anna C. Greene, PhD, NETRF Chief Scientific Officer Two recent NETRF-funded studies are offering new insight into how neuroendocrine tumors grow, spread, and respond
At the Neuroendocrine Tumor Research Foundation (NETRF), we support research that can move the field forward, not only by advancing new treatments, but also by
By Anna C. Greene, PhD, NETRF Chief Scientific Officer A new multi-institutional study provides one of the most comprehensive pictures to date of what life
Tijana Jovanovic-Talisman, PhD, is an Associate Professor at Beckman Research Institute at City of Hope and a 2025 NETRF Pilot Award grantee for her research
By Anna C. Greene, PhD, NETRF Chief Scientific Officer Scientists are discovering that where a tumor grows in the body may influence how it behaves.
For many families affected by neuroendocrine cancer, supporting research becomes a deeply personal mission. For Wayne Firsty and his children, Shay and Alana, that commitment
Clinical Trials Highlight Advances in Neuroendocrine Tumor Research Research into neuroendocrine tumors (NETs) continues to progress, with clinical trials exploring both new treatment approaches and
More than one thousand neuroendocrine cancer researchers, physicians, and patient advocates from over 50 countries gathered this month in Krakow, Poland, for the 23rd Annual
By Anna C. Greene, PhD, NETRF Chief Scientific Officer A new open-access review article in Virchows Archiv, “Novel concepts of cell-of-origin in neuroendocrine neoplasms,” by
Jamie Metzl is a writer and technology/health care futurist who regularly speaks to the medical industry on the future of health care. When Jamie’s father,